Get notified when IIPR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- SEC Investigation (unchanged) — SEC formal investigation initiated February 2026 related to allegations in the Giraudon securities class action; company received document subpoena from Denver Regional Office.
IIPR: revenue $63.3M, net income $43.9M. IIPR resolves going concern, issues exchangeable notes, faces new tenant defaults
Filed August 4, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 7, 2025 · ~2 min read
Key Changes
-
high
Company resolved going concern by repaying $291.2M Notes due 2026 at maturity in May 2026, funded by $402.5M exchangeable notes (6.00%, June 2029, exchange price $69.39/share) and $148.7M secured term loans.
Notes: Going Concern Resolution & Exchangeable Notes view on EDGAR → -
high
Three new tenant defaults declared: Cannabist (19 properties, 3.2% of rent, Canadian insolvency proceedings), Battle Green (combined 6.0% of rent with Cannabist), and Parallel (6.1% of rent, post-quarter July 2026 default on two Florida properties).
MD&A: Tenant Defaults verify on EDGAR → -
high
PharmaCann settlement resolved three defaulted properties (NY, OH, PA) via February 2026 agreement; Ohio re-leased to Curaleaf in April 2026, NY and PA remain in PharmaCann possession past surrender dates as license transfers are negotiated.
MD&A: PharmaCann Settlement verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Partner
Trade IIPR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 5, 2026 · How we verify